172 related articles for article (PubMed ID: 22067624)
1. Mild hypothermia decreases fentanyl and midazolam steady-state clearance in a rat model of cardiac arrest.
Empey PE; Miller TM; Philbrick AH; Melick JA; Kochanek PM; Poloyac SM
Crit Care Med; 2012 Apr; 40(4):1221-8. PubMed ID: 22067624
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic hypothermia-induced pharmacokinetic alterations on CYP2E1 chlorzoxazone-mediated metabolism in a cardiac arrest rat model.
Tortorici MA; Kochanek PM; Bies RR; Poloyac SM
Crit Care Med; 2006 Mar; 34(3):785-91. PubMed ID: 16521272
[TBL] [Abstract][Full Text] [Related]
3. Concentrations of remifentanil, propofol, fentanyl, and midazolam during rewarming from therapeutic hypothermia.
Bjelland TW; Klepstad P; Haugen BO; Nilsen T; Salvesen O; Dale O
Acta Anaesthesiol Scand; 2014 Jul; 58(6):709-15. PubMed ID: 24611449
[TBL] [Abstract][Full Text] [Related]
4. A little hypothermia goes a long way.
Lee SA; Alston TA
Crit Care Med; 2012 Apr; 40(4):1369-70. PubMed ID: 22425848
[No Abstract] [Full Text] [Related]
5. Cardiac arrest and therapeutic hypothermia decrease isoform-specific cytochrome P450 drug metabolism.
Zhou J; Empey PE; Bies RR; Kochanek PM; Poloyac SM
Drug Metab Dispos; 2011 Dec; 39(12):2209-18. PubMed ID: 21868471
[TBL] [Abstract][Full Text] [Related]
6. The effect of mild hypothermia on plasma fentanyl concentration and biotransformation in juvenile pigs.
Fritz HG; Holzmayr M; Walter B; Moeritz KU; Lupp A; Bauer R
Anesth Analg; 2005 Apr; 100(4):996-1002. PubMed ID: 15781513
[TBL] [Abstract][Full Text] [Related]
7. Moderate hypothermia may be detrimental after traumatic brain injury in fentanyl-anesthetized rats.
Statler KD; Alexander HL; Vagni VA; Nemoto EM; Tofovic SP; Dixon CE; Jenkins LW; Marion DW; Kochanek PM
Crit Care Med; 2003 Apr; 31(4):1134-9. PubMed ID: 12682484
[TBL] [Abstract][Full Text] [Related]
8. Effects of hypothermia on the disposition of morphine, midazolam, fentanyl, and propofol in intensive care unit patients.
Bjelland TW; Klepstad P; Haugen BO; Nilsen T; Dale O
Drug Metab Dispos; 2013 Jan; 41(1):214-23. PubMed ID: 23115086
[TBL] [Abstract][Full Text] [Related]
9. Moderate hypothermia prevents cardiac arrest-mediated suppression of drug metabolism and induction of interleukin-6 in rats.
Tortorici MA; Mu Y; Kochanek PM; Xie W; Poloyac SM
Crit Care Med; 2009 Jan; 37(1):263-9. PubMed ID: 19050605
[TBL] [Abstract][Full Text] [Related]
10. Comparing anesthesia with isoflurane and fentanyl/fluanisone/midazolam in a rat model of cardiac arrest.
Secher N; Malte CL; Tønnesen E; Østergaard L; Granfeldt A
J Appl Physiol (1985); 2017 Nov; 123(4):867-875. PubMed ID: 27125849
[TBL] [Abstract][Full Text] [Related]
11. Effects of hypothermia on drug disposition, metabolism, and response: A focus of hypothermia-mediated alterations on the cytochrome P450 enzyme system.
Tortorici MA; Kochanek PM; Poloyac SM
Crit Care Med; 2007 Sep; 35(9):2196-204. PubMed ID: 17855837
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of hypothermia on the in vitro metabolism and binding and in vivo disposition of midazolam in rats.
Miyamoto H; Matsueda S; Moritsuka A; Shimokawa K; Hirata H; Nakashima M; Sasaki H; Fumoto S; Nishida K
Biopharm Drug Dispos; 2015 Oct; 36(7):481-9. PubMed ID: 26037413
[TBL] [Abstract][Full Text] [Related]
13. Propofol decreases the clearance of midazolam by inhibiting CYP3A4: an in vivo and in vitro study.
Hamaoka N; Oda Y; Hase I; Mizutani K; Nakamoto T; Ishizaki T; Asada A
Clin Pharmacol Ther; 1999 Aug; 66(2):110-7. PubMed ID: 10460064
[TBL] [Abstract][Full Text] [Related]
14. Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study.
Su J; Chang C; Xiang Q; Zhou ZW; Luo R; Yang L; He ZX; Yang H; Li J; Bei Y; Xu J; Zhang M; Zhang Q; Su Z; Huang Y; Pang J; Zhou SF
Drug Des Devel Ther; 2014; 8():2555-602. PubMed ID: 25548518
[TBL] [Abstract][Full Text] [Related]
15. Effect of Hypothermia and Targeted Temperature Management on Drug Disposition and Response Following Cardiac Arrest: A Comprehensive Review of Preclinical and Clinical Investigations.
Anderson KB; Poloyac SM; Kochanek PM; Empey PE
Ther Hypothermia Temp Manag; 2016 Dec; 6(4):169-179. PubMed ID: 27622966
[TBL] [Abstract][Full Text] [Related]
16. Minor contribution of cytochrome P450 3A activity on fentanyl exposure in palliative care cancer patients.
Geist MJP; Ziesenitz VC; Bardenheuer HJ; Burhenne J; Skopp G; Mikus G
Sci Rep; 2019 Oct; 9(1):14635. PubMed ID: 31601999
[TBL] [Abstract][Full Text] [Related]
17. Alteration of drug-metabolizing enzyme activity in palliative care patients: Microdosed assessment of cytochrome P450 3A.
Geist M; Bardenheuer H; Burhenne J; Mikus G
Palliat Med; 2019 Jul; 33(7):850-855. PubMed ID: 31023150
[TBL] [Abstract][Full Text] [Related]
18. Effect of borneol on cytochrome P450 3A enzyme and midazolam pharmacokinetics in rats.
Zhang R; Mi SQ; Wang NS
Eur J Drug Metab Pharmacokinet; 2013 Sep; 38(3):159-69. PubMed ID: 23589122
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients.
de Wildt SN; de Hoog M; Vinks AA; van der Giesen E; van den Anker JN
Crit Care Med; 2003 Jul; 31(7):1952-8. PubMed ID: 12847388
[TBL] [Abstract][Full Text] [Related]
20. Predicting CYP3A-mediated midazolam metabolism in critically ill neonates, infants, children and adults with inflammation and organ failure.
Brussee JM; Vet NJ; Krekels EHJ; Valkenburg AJ; Jacqz-Aigrain E; van Gerven JMA; Swart EL; van den Anker JN; Tibboel D; de Hoog M; de Wildt SN; Knibbe CAJ
Br J Clin Pharmacol; 2018 Feb; 84(2):358-368. PubMed ID: 29072785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
